Vimab Group AB (OSTO:VIMAB) Total Stockholders Equity: kr5.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
57 GF Score
Price kr4.40
GF Value kr5.54
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB Total Stockholders Equity?

Vimab Group AB OSTO:VIMAB -5.17% 57 Total Stockholders Equity is kr5.0 Mil as of Jun. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 57/100 and a GF Value™ of kr5.54 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Vimab Group AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr5.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vimab Group AB's Book Value per Share for the quarter that ended in Jun. 2026 was kr0.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vimab Group AB's Debt-to-Equity for the quarter that ended in Jun. 2026 was 20.75.

Vimab Group AB  (OSTO:VIMAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vimab Group AB's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(4.978-0)/47.562
=0.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vimab Group AB's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(99.479 + 3.83) / 4.978
=20.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Total Stockholders Equity Related Terms

Vimab Group AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Total Stockholders Equity Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.77 56.82 78.66 17.75 36.12

Vimab Group AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.58 -7.13 36.12 14.23 4.98
OSTO:VIMAB
57GF Score
Vimab Group AB OSTO:VIMAB
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of kr5.0 Mil mean?
Vimab Group AB (OSTO:VIMAB) has a Total Stockholders Equity of kr5.0 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Vimab Group AB and its competitors.
Is Vimab Group AB's Total Stockholders Equity too high?
Vimab Group AB's current Total Stockholders Equity is kr5.0 Mil. Overall, Vimab Group AB has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Total Stockholders Equity compare to VRSK and EFX?
Vimab Group AB's Total Stockholders Equity of kr5.0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Business Services company?
A good Total Stockholders Equity depends on the Business Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Vimab Group AB and its competitors. Vimab Group AB's current Total Stockholders Equity is kr5.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Modestly Undervalued. The stock's GF Value™ is kr5.54, compared to a current price of kr4.40 — trading 20.6% below its estimated fair value. The current Total Stockholders Equity is kr5.0 Mil. Vimab Group AB's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Total Stockholders Equity is kr5.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr4.40 is trading 20.6% below its estimated GF Value™ of kr5.54. GuruFocus considers Vimab Group AB to be Modestly Undervalued.

Key valuation signals for OSTO:VIMAB:

  • Total Stockholders Equity: kr5.0 Mil
  • GF Value™: kr5.54 vs. price of kr4.40 (20.6% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
57GF Score

Get the complete analysis for OSTO:VIMAB

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.40
Price
kr5.54
GF Value